Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 9;13:10075–10085. doi: 10.2147/OTT.S262909

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Fan et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

SNX20 expression is correlate with immune infiltration level in lung adenocarcinoma and predicts good prognosis. (A) The correlation of SNX20 and immune infiltration in lung adenocarcinoma in the TISIDB database. (B) The correlations between SNX20 and immune infiltration level in the TIMER databases. (C and D) The correlation between the expression of SNX20 and sets gene marker of monocytes (CD86, CSF1R) and TAMs (CCL2, CD68, IL10) in TIMER database. (E) High SNX20 expression predicts a good prognosis for patients with lung adenocarcinoma in TCGA.

Abbreviations: CCL2, C-C motif chemokine ligand 2; CD68, cluster of differentiation 68; CD86, cluster of differentiation 86; CSF1R, colony stimulating factor 1 receptor; IL10, interleukin 10; SNX, sorting nexin; TAMs, tumor-associated macrophages; TCGA, The Cancer Genome Atlas; TIMER, Tumor Immune Estimation Resource; TISIDB, tumor and immune system interaction.